We have seen the first few cases in Europe where FDI decisions by a national regulator have been challenged in court. What trends are we seeing so far and the lessons learned?

• Analysing the increased interaction between Member States via the EU screening mechanism and whether such information exchange and interaction leads to more FDI filings/investigations
• Examining recent developments in Europe – what new FDI regimes will come into force, or further expansion to existing regimes? What will this mean in practice?
• Determining the recent European Commission economic strategy and its proposed changes to the EU FDI regulation
• Reviewing recent court decisions, including:
  • BMWK’s prohibition of the acquisition of PCK Raffinerie GmbH
  • BMWK’s prohibition of the acquisition of the German medical device manufacturer Heyer Medical AG
  • Italian government prohibited acquisition of Microtecnica
  • Recent Xella decision by the European Court of Justice
• Will there be a reduction in regulatory hurdles as FDI Regimes continue to evolve and as courts continue to scrutinise the substantive review, commitments and procedural rights?